Company / Current Liabilities per Share
Processa Pharmaceuticals, Inc. Current Liabilities per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.06
FY2022
5-year range
$0.06 / $0.21
FY2018-FY2022
Trend
-7.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.21 to $0.06 over the past 6 years.
Based on SEC 10-K filings.
0.06 in FY2022.
Improved from $0.21 to $0.06 over the past 6 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, current liabilities per share decreased 7.2% year-over-year.
- Peak current liabilities per share was recorded in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.06 | -7.2% |
| FY2021 | $0.07 | -68.0% |
| FY2016 | $0.21 | +12.4% |
| FY2015 | $0.19 | +83.0% |
| FY2014 | $0.10 | -82.9% |
| FY2013 | $0.61 | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026